Xeltis Hemodialysis Access Graft: aXess Pivotal Study

Clinical trial NCT05473299 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05473299
Sponsor: Xeltis
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

End-stage Renal Disease

Start date: 2022-11-04
Primary completion: 2025-06-23
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.